Preparation method of tadalafil nitrosamine impurity
By using a specific solvent and nitrosating agent under mild conditions for nitrosation reaction, the problem of low yield in the preparation of tadalafil nitrosamine impurities was solved, and the preparation of high-purity impurities was achieved, meeting the needs of toxicological research and drug quality control, and improving drug safety and regulatory compliance.
Patent Information
- Application Number
- CN202511356014.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-09-22
- Publication Date
- 2026-01-13
AI Technical Summary
The existing technology for preparing tadalafil nitrosamine impurities has low yield and low purity, making it difficult to meet the needs of batch analysis. It also lacks reliable standards, which affects drug quality control and regulatory compliance.
The nitrosation reaction is carried out under mild and controllable conditions using specific organic solvents and nitrosating agents, including the use of nitrites or nitrite esters as nitrosating agents, combined with acidic reagents and different solvents. By optimizing reaction parameters and post-processing methods, high-purity nitrosamine impurities can be prepared efficiently.
This method achieves high yield and high purity preparation of tadalafil nitrosamine impurities, providing key materials for toxicological studies and drug safety testing, meeting qualitative and quantitative analysis requirements, and ensuring drug quality and compliance.
Smart Images

Figure CN121318968A_ABST
Abstract
Citation Information
Patent Citations
Preparing method of phosphodiesterase 5 inhibitor tadalafil
CN103980275A
